The molecular underpinnings of oligodendrocyte dysfunction in HD involve mHTT-mediated disruption of key transcriptional regulators such as MYRF and TCF7L2, dysregulated lipid and thiamine metabolism, altered BDNF signaling, and epigenetic dysregulation. This evidence concerns the gene BDNF and Huntington disease.